Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors”

414 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 414 results

Testing effectiveness (Phase 2)Study completedNCT01524848
What this trial is testing

Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Scandinavian Sarcoma Group 72
Early research (Phase 1)Study completedNCT03411915
What this trial is testing

XmAb®18087 in Subjects With NET and GIST

Who this might be right for
Neuroendocrine TumorGastrointestinal Neoplasm
Xencor, Inc. 62
Large-scale testing (Phase 3)Looking for participantsNCT06640361
What this trial is testing

Olverembatinib in SDH-deficient GIST.

Who this might be right for
GIST
Ascentage Pharma Group Inc. 40
Testing effectiveness (Phase 2)Study completedNCT02015065
What this trial is testing

Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors

Who this might be right for
GIST
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT03609424
What this trial is testing

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Early research (Phase 1)Active Not RecruitingNCT05489237
What this trial is testing

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal NeoplasmsGastrointestinal Stromal Tumor (GIST)Digestive System Disease+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC 276
Not applicableStudy completedNCT04487002
What this trial is testing

Outcome After Surgical Resection of Gastrointestinal Stromal Tumors (GIST) in the Second Part of Duodenum

Who this might be right for
Gastrointestinal Stromal Tumor of Duodenum
Alexandria University 53
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableNot Yet RecruitingNCT07724626
What this trial is testing

Hyperpolarized MRI for GIST on Imatinib

Who this might be right for
Imatinib Therapy ResponseGastrointestinal Stromal Tumor (GIST)
Chang Gung Memorial Hospital 30
Not applicableStudy completedNCT02106858
What this trial is testing

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

Who this might be right for
Colorectal Neoplasms
Bayer 316
Not applicableUnknownNCT05132738
What this trial is testing

Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy

Who this might be right for
Gastrointestinal Stromal Tumors
RenJi Hospital 20
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Not applicableLooking for participantsNCT07078136
What this trial is testing

Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis

Who this might be right for
Submucosal TumorGastrointestinal Stromal Tumor (GIST)Leiomyoma+1 more
Huazhong University of Science and Technology 130
Not applicableStudy completedNCT00976612
What this trial is testing

Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 17
Not applicableUnknownNCT02443948
What this trial is testing

Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Fondazione del Piemonte per l'Oncologia 60
Early research (Phase 1)Ended earlyNCT00573404
What this trial is testing

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Vanderbilt-Ingram Cancer Center 6
Next Page